Fund Details
Overview
Investment portfolio
8rounds
| NAME | DATE | SIZE | |
|---|---|---|---|
Precision Neuroscience | Sep 2026Participated | $250 MSeries D | |
Network Bio | Aug 2026Participated | $50 MOther Equity | |
Connie Health | Jun 2026Participated | $40 MSeries B | |
Beacon Biosignals | Apr 2026Participated | $11 MSeries B | |
Radial | Dec 2025Participated | $50 MSeries A | |
Synfini | Jul 2025Led | $9 MOther Equity | |
Rippl | Oct 2024Participated | $23 MSeries A | |
Rippl | Oct 2024Participated | $23 MSeries A | |
Precision Neuroscience | Sep 2026Participated | $250 MSeries D | |
Network Bio | Aug 2026Participated | $50 MOther Equity | |
Connie Health | Jun 2026Participated | $40 MSeries B | |
Beacon Biosignals | Apr 2026Participated | $11 MSeries B | |
Radial | Dec 2025Participated | $50 MSeries A | |
Synfini | Jul 2025Led | $9 MOther Equity | |
Rippl | Oct 2024Participated | $23 MSeries A | |
Rippl | Oct 2024Participated | $23 MSeries A |
8 Items
8
Items
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 0 | 3 |
| Series B | 0 | 2 |
| Series C+ | 0 | 1 |
| Other Equity | 1 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Oct '24 | 2 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 1 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 1 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 1 |
| May '26 | 0 |
| Jun '26 | 1 |
| Jul '26 | 0 |
| Aug '26 | 1 |
| Sep '26 | 1 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 7 |
| AI & Machine Learning | 3 |
| Space & Frontier Tech | 2 |
| Networks, Cloud & Communication | 1 |
| Hardware & Robotics | 1 |
| Professional Services | 1 |
| Consumer & Lifestyle | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 1 |
| $10M-$25M | 3 |
| $25M-$50M | 1 |
| $50M-$100M | 2 |
| $100M-$250M | 0 |
| $250M-$500M | 1 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 7 |
| India | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| General Catalyst | 4 |
| Google Ventures | 3 |
| 1843 Capital | 2 |
| ARCH Venture Partners | 2 |
| F-Prime Capital | 2 |
| Kin Ventures | 2 |
| Mass General Brigham Ventures | 2 |
| Section 32 | 2 |
| Ackman Oxman Institute | 1 |
| aMoon | 1 |
| ARK Invest | 1 |
| B Capital Group | 1 |
| BlueCross BlueShield Venture Partners | 1 |
| BoxGroup | 1 |
| Breyer Capital | 1 |
| Casdin Capital | 1 |
| Catalio Capital Management | 1 |
| Duquesne Family Office | 1 |
| Ferocity Capital | 1 |
| Foothill Ventures | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 1 | 13% |
| Participating | 7 | 88% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 1 | 100% |
| Co-led | 0 | 0% |
Team
Alex Turkeltaub
Founder and Managing Partner
Lekan Wang
General Partner